Drug Abuse Testing Market Size, Trends, Growth & Outlook

Drug Abuse Testing Market by Product & Services (Analyzers, Rapid Testing Devices, Consumables, and Laboratory Services), Sample Type (Urine, Oral Fluid, Breath, Hair, and Others), and End User (Workplaces & Schools, Criminal Justice Systems & Law Enforcement Agencies, Research Laboratories, and Hospitals): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Industry: Life Science | Report ID: FAMI-00213 | Published on: Sep, 2019 | View: 268 | Share:         

Request Sample Enquire Before Buying Request Discount

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

The global drug abuse testing market was valued at $6,244 million in 2017 and is expected to reach $11,833 million by 2025, registering a CAGR of 8.2% from 2018 to 2025.

A drug test is primarily performed to confirm the presence of one or more illegal or prescription drugs in a person’s urine, blood, saliva, hair, or sweat. The test is performed by using the samples such as urine, hair, blood, saliva, and others. Among these urine sample is the most widely preferred owing to the advantages it offers, such as lower test cost, availability of more sample, and availability of point-of-care tests. Drug testing offers a critical adjunct to clinical care and substance use. The most often tested drugs include marijuana, opioids, cocaine, morphine, and others. Drug tests are increasingly being adopted by sports organizations, employers, forensic purposes, and several other applications.

The surge in consumption of alcohol and illicit drugs across the globe is one of the major drivers for the drug testing market. In addition, technological advancements toward the development of more accurate and precise testing devices and stringent government regulations mandating drug abuse monitoring further boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market. On the contrary, emerging markets such as the Asia-Pacific and LAMEA, provide lucrative growth opportunities for the market.

The global drug abuse testing market is segmented based on products & services, sample type, end user, and region. Based on products & services, it is divided into equipment, rapid testing devices (RTD), consumables, and laboratory services. Based on equipment, it is further categorized into immunoassay analyzers, chromatography instruments, and breath analyzers. Based on RTD, it is bifurcated into urine testing devices and oral fluid/saliva testing devices. Based on consumables, it is divided into assay kits, sample collection cups, calibrators & controls, and other consumables. Based on sample type, the market is divided into urine sample, breath sample, oral fluid sample, hair sample, and others.

Based on end user, it is segmented into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, pain management centers, and personal users. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for drug abuse testing market:

    The study provides an in-depth analysis of the global drug abuse testing market along with the current trends and future estimations to elucidate the imminent investment pockets.

    A comprehensive analysis of the factors that drive and restrict the market growth is provided.

    A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

    An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.

    Key players and their strategies are provided to understand the competitive outlook of the industry.

Drug Abuse Testing Key Market Segments:

By Product & Services

    Analyzers
    Consumables
    Rapid Testing Devices
    Laboratory Services

By Sample Type

    Urine
    Oral Fluid (Saliva)
    Hair
    Breath
    Others

By End User

    Workplaces & Schools
    Criminal Justice Systems and Law Enforcement Agencies
    Research Laboratories
    Hospitals

By Region

    North America
        U.S.
        Canada
        Mexico
    Europe
        UK
        France
        Germany
        Italy
        Spain
        Rest of Europe
    Asia-Pacific
        Japan
        China
        India
        Australia
        Rest of Asia-Pacific
    LAMEA
        Saudi Arabia
        South Africa
        Brazil
        Turkey
        Rest of LAMEA

Key Market Players:

    Drägerwerk AG & Co
    Abbott Laboratories
    Hoffmann-La Roche AG
    Bio Rad Laboratories, Inc.
    Siemens AG
    Thermo Fisher Scientific, Inc.
    Danaher Corporation
    Quest Diagnostics Incorporated
    Express Diagnostics International Inc.
    Laboratory Corporation of America Holdings

The other players in the value chain include (profiles not included in the report):

    OraSure
    Alfa Scientific Designs
    Lifeloc
    MPD, Inc
    Premier Biotech
    Shimadzu
    Psychemedics
    SureHire
    CannAmm
    Omega Laboratories
 

Get a sample pages of this report Click here

"CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for the stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Stringent government regulations regarding drug abuse
3.5.1.2. Rise in awareness against drug abuse
3.5.1.3. Development of novel drug testing equipment

3.5.2. Restraints

3.5.2.1. Consideration of drug abuse testing as a violation of rights
3.5.2.2. Possible manipulation of drug screening tests

3.5.3. Opportunities

3.5.3.1. Development of novel drug screening tests

CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE

4.1. Overview

4.1.1. Market size and forecast

4.2. Analyzers

4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Immunoassay analyzers

4.2.4.1. Market size and forecast

4.2.5. Chromatography analyzers

4.2.5.1. Market size and forecast

4.2.6. Breath analyzers

4.2.6.1. Market size and forecast

4.3. Rapid Testing Devices

4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Urine testing devices

4.3.4.1. Market size and forecast
4.3.4.2. Urine testing devices, by type market size and forecast

4.3.4.2.1. Market size and forecast

4.3.5. Oral fluid testing devices

4.3.5.1. Market size and forecast

4.4. Consumables

4.4.1. Key trends and opportunities

4.4.1.1. Market size and forecast

4.4.2. Market analysis, by country

4.4.2.1. Assay kits

4.4.2.1.1. Market size and forecast

4.4.2.2. Sample collection cups

4.4.2.2.1. Market size and forecast

4.4.2.3. Calibrators and controls

4.4.2.3.1. Market size and forecast

4.4.2.4. Others

4.4.2.4.1. Market size and forecast

4.5. Laboratory Services

4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country

CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Urine

5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.3. Oral Fluid

5.2.3.1. Market size and forecast

5.2.4. Market analysis, by country
5.2.5. Breath

5.2.5.1. Market size and forecast

5.2.6. Market analysis, by country
5.2.7. Hair

5.2.7.1. Market size and forecast

5.2.8. Market analysis, by country
5.2.9. Other Samples

5.2.9.1. Market size and forecast

5.2.10. Market analysis, by country

CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Workplaces and Schools

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Criminal Justice Systems and Law Enforcement Agencies

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Research laboratories

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

6.5. Hospitals

6.5.1. Market size and forecast
6.5.2. Market analysis, by country

CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key trends and opportunities
7.2.2. North America market size and forecast, by country

7.2.2.1. U.S. market size and forecast, by product & service
7.2.2.2. U.S. market size and forecast, by sample type
7.2.2.3. U.S. market size and forecast, by end user
7.2.2.4. Canada market size and forecast, by product & service
7.2.2.5. Canada market size and forecast, by sample type
7.2.2.6. Canada market size and forecast, by end user
7.2.2.7. Mexico market size and forecast, by product & service
7.2.2.8. Mexico market size and forecast, by sample type
7.2.2.9. Mexico market size and forecast, by end user
7.2.2.10. North America market size and forecast, by product & service

7.2.3. North America market size and forecast, by sample type
7.2.4. North America market size and forecast, by end user

7.3. Europe

7.3.1. Key trends and opportunities
7.3.2. Europe market size and forecast, by country

7.3.2.1. Germany market size and forecast, by product & service
7.3.2.2. Germany market size and forecast, by sample type
7.3.2.3. Germany market size and forecast, by end user
7.3.2.4. UK market size and forecast, by product & service
7.3.2.5. UK market size and forecast, by sample type
7.3.2.6. UK market size and forecast, by end user
7.3.2.7. France market size and forecast, by product & service
7.3.2.8. France market size and forecast, by sample type
7.3.2.9. France market size and forecast, by end user
7.3.2.10. Rest of Europe market size and forecast, by product & service
7.3.2.11. Rest of Europe market size and forecast, by sample type
7.3.2.12. Rest of Europe market size and forecast, by end user

7.3.3. Europe market size and forecast, by product & service
7.3.4. Europe market size and forecast, by sample type
7.3.5. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country

7.4.2.1. Japan market size and forecast, by product & service
7.4.2.2. Japan market size and forecast, by sample type
7.4.2.3. Japan market size and forecast, by end user
7.4.2.4. China market size and forecast, by product & service
7.4.2.5. China market size and forecast, by sample type
7.4.2.6. China market size and forecast, by end user
7.4.2.7. India market size and forecast, by product & service
7.4.2.8. India market size and forecast, by sample type
7.4.2.9. India market size and forecast, by end user
7.4.2.10. Australia market size and forecast, by product & service
7.4.2.11. Australia market size and forecast, by sample type
7.4.2.12. Australia market size and forecast, by end user
7.4.2.13. Rest of Asia-Pacific market size and forecast, by product & service
7.4.2.14. Rest of Asia-Pacific market size and forecast, by sample type

7.4.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.4. Asia-Pacific market size and forecast, by product & service
7.4.5. Asia-Pacific market size and forecast, by sample type
7.4.6. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by country

7.5.2.1. Brazil market size and forecast, by product & service
7.5.2.2. Brazil market size and forecast, by sample type
7.5.2.3. Brazil market size and forecast, by end user
7.5.2.4. South Africa market size and forecast, by product & service
7.5.2.5. South Africa market size and forecast, by sample type
7.5.2.6. South Africa market size and forecast, by end user
7.5.2.7. Saudi Arabia market size and forecast, by product & service
7.5.2.8. Saudi Arabia market size and forecast, by sample type
7.5.2.9. Saudi Arabia market size and forecast, by end user
7.5.2.10. Turkey market size and forecast, by product & service
7.5.2.11. Turkey market size and forecast, by sample type
7.5.2.12. Turkey market size and forecast, by end user
7.5.2.13. Rest of LAMEA market size and forecast, by product & service
7.5.2.14. Rest of LAMEA market size and forecast, by sample type
7.5.2.15. Rest of LAMEA market size and forecast, by end user

7.5.3. LAMEA market size and forecast, by product & service
7.5.4. LAMEA market size and forecast, by sample type
7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. BIO-RAD LABORATORIES INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Product portfolio

8.3. DANAHER CORPORATION

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. DRGERWERK AG & CO. KGAA

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. EXPRESS DIAGNOSTICS INTERNATIONAL INC.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments

8.6. F. HOFFMANN-LA ROCHE LTD. (GENENTECH INC.)

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. LABORATORY CORPORATION OF AMERICA HOLDINGS

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance

8.8. QUEST DIAGNOSTICS INCORPORATED

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance

8.9. SIEMENS AG

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. THERMO FISHER SCIENTIFIC INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance"

Select License Type
  • Single User License $5370 USD
  • Multi-User License $6450 USD
  • Corporate User License $8995 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.